HOME › DRUGS › CATUMAXOMAB
ACTIVE SUBSTANCE / INN

CATUMAXOMAB

Brand name(s): Korjuny, Removab
EMA LISTED
WITHDRAWN
AUTHORISED
Ascites;Cancer
Ascites
ACTIVE SUBSTANCE
Catumaxomab
REGULATORS
EMA
SPONSORS / MAH
Atnahs Pharma Netherlands B.V., Neovii Biotech GmbH
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
KorjunyAtnahs Pharma Netherlands B.V.Authorised10/02/2025Ascites
RemovabNeovii Biotech GmbHWithdrawn20/04/2009Ascites;Cancer

FULL INTELLIGENCE ON CATUMAXOMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →